PCOS, insulin resistance, and GLP-1s: sorting signal from supplement noise

What's this video probably claiming?

Based on the caption tags and the four supplement brands mentioned, Nicole is likely walking through a PCOS management stack, probably arguing that insulin resistance is the root driver of PCOS weight gain and that a combination of supplements, possibly including inositol, berberine, or magnesium, can work alongside or even substitute for GLP-1 receptor agonists like semaglutide or tirzepatide. The brand tags, MaryRuth's, Toni Rose, Theralogix, and Integrative Therapeutics, collectively sell inositol blends, omega-3s, CoQ10, and berberine products that are heavily marketed to the PCOS community. Given the GLP-1 category flag on this video, she may also be comparing natural alternatives to Ozempic or framing supplements as a gentler first step. That framing is popular. It is also where the evidence starts to get complicated.

What does the science actually show?

The insulin-PCOS connection is real and well-documented. Approximately 65-80% of women with PCOS show some degree of insulin resistance, regardless of BMI (Diamanti-Kandarakis and Dunaif, 2012, Endocrine Reviews). The most evidence-backed non-prescription intervention is myo-inositol, typically at 2-4g per day, often combined with D-chiro-inositol in a 40:1 ratio. A 2019 meta-analysis by Unfer et al. in Gynecological Endocrinology found improvements in fasting insulin, HOMA-IR, and menstrual regularity. Berberine has shown modest effects on insulin sensitivity in small trials, with a 2012 study in European Journal of Endocrinology reporting HbA1c reductions comparable to metformin in type 2 diabetics, though PCOS-specific data is thinner. GLP-1 receptor agonists, particularly semaglutide 2.4mg weekly, produced 14.9% mean body weight reduction in the STEP 1 trial (Wilding et al., 2021, NEJM). None of the supplement brands tagged in this video have comparable clinical data.

Where does the social media noise diverge from clinical reality?

The biggest distortion in PCOS content is treating insulin resistance as a single, fixable variable when it is a symptom cluster with multiple drivers, including androgen excess, hypothalamic-pituitary dysfunction, and gut microbiome differences. Supplements that nudge insulin sensitivity do not address elevated LH/FSH ratios, hyperandrogenism, or ovulatory dysfunction in any clinically meaningful way for most patients. Another common slip is presenting GLP-1 drugs and supplement stacks as equivalent choices. They are not. Semaglutide and tirzepatide work through receptor-level hormonal signaling with documented effects on appetite regulation, gastric emptying, and beta-cell function. Inositol works through a different mechanism entirely and has not been tested head-to-head against GLP-1 agonists in PCOS populations at scale. Creators also rarely mention that berberine can interact with metformin and certain CYP3A4-metabolized medications, which matters for a population that is frequently prescribed both.

What should you actually know?

If you have PCOS and insulin resistance, the evidence supports myo-inositol as a reasonable adjunct, particularly if you are not a candidate for or prefer to delay pharmacological intervention. The 40:1 myo to D-chiro-inositol ratio used in Theralogix's Ovasitol product does reflect the physiological plasma ratio studied in clinical trials. That specificity matters. What the supplement industry does not tell you is that for women with moderate to severe insulin resistance and BMI over 30, GLP-1 medications are likely to produce substantially greater metabolic and reproductive improvements than any supplement stack. A 2023 retrospective analysis in Fertility and Sterility found that semaglutide improved menstrual regularity in 77% of women with PCOS who completed 6 months of treatment. Supplements are not a replacement for that level of effect. Talk to a clinician who actually looks at your fasting insulin, HOMA-IR, testosterone, and LH levels before building any protocol around what a TikTok stack recommends.